Abstract Number: 1149 • ACR Convergence 2021
Efficacy of Alendronate for Prevention of New Fractures and Vertebral Deformities in Patients with Rheumatologic Disorders on Chronic Glucocorticoid Therapy: A Systematic Review and Meta-analysis
Background/Purpose: Glucocorticoids are commonly used in patients with rheumatologic conditions including but not limited to Rheumatoid Arthritis, Polymyalgia Rheumatica, Systemic Lupus Erythematous and so on.…Abstract Number: 270 • 2019 ACR/ARP Annual Meeting
Outcomes of a Fracture Liaison Service at an Academic Health Center
Background/Purpose: Osteoporosis is associated with increased morbidity and mortality. There is a 60% risk of a subsequent fracture for patients who have had one fracture,…Abstract Number: 272 • 2019 ACR/ARP Annual Meeting
Osteoporosis Management Outcomes in a Southern California County Health System
Background/Purpose: Fragility fractures (FF) are a sentinel event in osteoporosis and world-wide only 20% of patients with a FF receive treatment, a large care gap.…Abstract Number: 1929 • 2019 ACR/ARP Annual Meeting
Identification and Validation of Transcriptional Genes Associated with Osteoporotic Vertebral Fractures by Microarray Study, in Community Elderly Women
Background/Purpose: The pathogenesis of osteoporosis, a common disease with high morbidity1, comprises genetic and environmental factors2. Recent studies demonstrated that blood samples are a source…Abstract Number: 2204 • 2019 ACR/ARP Annual Meeting
Fragility Fractures in a Community Setting: Clinical Characteristics, Care Gaps, and Outcomes
Background/Purpose: Osteoporosis-related fragility fractures contribute to significant morbidity and mortality. The risk of subsequent hip fracture is significantly increased after initial fracture, with some reports…Abstract Number: 2305 • 2018 ACR/ARHP Annual Meeting
Peripheral Arterial Disease Is Associated with an Increased Risk of Subsequent Hip Fracture: A Systematic Review and Meta-Analysis of Cohort Studies
Peripheral Arterial Disease is Associated with an Increased Risk of Subsequent Hip Fracture: A Systematic Review and Meta-Analysis of Cohort Studies AbstractBackground/Purpose: Studies have suggested…Abstract Number: 2307 • 2018 ACR/ARHP Annual Meeting
In the 21st Century: Is Still Rheumatoid Arthritis a Risk Factor for Osteoporotic Fractures?
Background/Purpose: Rheumatoid Arthritis (RA) has been considered an independent osteoporotic risk factor. Nowadays, RA patients have a better disease control and corticosteroid use is less…Abstract Number: 2308 • 2018 ACR/ARHP Annual Meeting
Abaloparatide for Risk Reduction of Nonvertebral and Vertebral Fractures in Postmenopausal Women with Osteoporosis: A Network Meta-Analysis
Background/Purpose: To assess the relative efficacy of abaloparatide compared with other osteoporosis treatment options (alendronate, denosumab, ibandronate, raloxifene, risedronate, romosozumab, strontium ranelate, teriparatide, zoledronic acid).…Abstract Number: 2326 • 2018 ACR/ARHP Annual Meeting
Outcomes One Year after Hip Fracture Repair in the Elderly: Does Social Isolation Matter?
Background/Purpose: Hip fractures are a serious public health issue with a significant population burden, especially among those over age 65. Social isolation—how integrated a patient…Abstract Number: 2335 • 2018 ACR/ARHP Annual Meeting
Osteoporotic Fracture Trends in a Population of US Managed Care Enrollees: 2007-2017
Background/Purpose: Osteoporosis-related fractures (fractures) are a leading cause of morbidity and disability in the US. Epidemiological data on the occurrence of fractures are limited and…Abstract Number: 2337 • 2018 ACR/ARHP Annual Meeting
Vertebral Compression Fractures and Antibodies to Citrullinated Vimentin in Established Rheumatoid Arthritis
Background/Purpose: Patients with RA have high rates of osteoporosis and fractures and RA induces articular and extra-articular bone loss. Seropositivity for any CCP antibody is…Abstract Number: 2809 • 2018 ACR/ARHP Annual Meeting
Skeletal Benefit/Risk of Long-Term Denosumab Therapy: A Virtual Twin Analysis of Fractures Prevented to Skeletal Safety Events Observed
Background/Purpose: Osteoporosis is a chronic disease, yet skeletal safety events—atypical femoral fracture (AFF) and osteonecrosis of the jaw (ONJ)—remain a concern with long-term treatment. Ten…Abstract Number: 2174 • 2018 ACR/ARHP Annual Meeting
Self-Report of Fracture History Compared to Fracture Codes from an Electronic Health Record Dataset
Background/Purpose: Self-reported fracture (fx) history data is frequently used in epidemiological studies of osteoporosis. Self-reported fx data may differ from fx history coded in electronic…Abstract Number: 304 • 2017 ACR/ARHP Annual Meeting
Usefulness of Consecutive Doppler Ultrasound Examinations for Detecting Deep Venous Thrombosis during the Perioperative Period in Patients with Osteoporotic Fractures of the Proximal Femur
Background/Purpose: Deep venous thrombosis (DVT) can lead to a venous thromboembolism and increase the risk of a pulmonary thromboembolism (PE). PE is one of the…Abstract Number: 318 • 2017 ACR/ARHP Annual Meeting
A Randomized Alendronate-Controlled Trial of Romosozumab: Results of the Phase 3 Active-Controlled Fracture Study in Postmenopausal Women with Osteoporosis at High Risk
Background/Purpose: The bone forming agent romosozumab (Romo) was previously shown to reduce vertebral and clinical fractures in postmenopausal women with osteoporosis. Here we report the…
- 1
- 2
- 3
- …
- 5
- Next Page »